Background: The glucocorticoid receptor (GR) is frequently expressed in breast cancer (BC). and its prognostic implications are contingent on estrogen receptor (ER) status. To address conflicting reports and explore therapeutic potential. a GR signature (GRsig) independent of ER status was developed. https://www.rawafricaonline.com/